Founders / Eliav Shaked
RetiSpec
AI analysis of hyperspectral retinal images to detect Alzheimer's disease pathology through an eye test.
- Role
- Co-founder & CEO
- HQ
- Toronto, ON
- Founded
- 2016
- Status
- Active
- Disclosed raised
- US$10M
- Latest round
- Series A, Jul 26, 2024
Investors: iGan Partners, Eli Lilly and Company, Topcon Healthcare, Gentex Corporation, Alzheimer's Drug Discovery Foundation Diagnostics Accelerator, Verge HealthTech Fund, Discovery Capital (University of Minnesota), Ontario Brain Institute, and 1 more
Founders are listed as named in primary coverage of their companies. Profile links are matched to the company before they are published. To correct this page or ask for it to be removed, email the Index.
Data as of September 29, 2026.